NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Dottikon ES Holding AG Logo
Manufactures chemicals and APIs, specializing in hazardous reactions.
Switzerland
DESN
Double Bond Pharmaceutical International AB Logo
Redevelops drugs with targeted delivery to improve safety and efficacy.
Sweden
DBP B
DR REDDYS LABORATORIES LTD Logo
An integrated global pharmaceutical company providing affordable and innovative medicines.
United States of America
RDY
Drugs Made In America Acquisition Corp. Logo
A SPAC targeting U.S.-based pharmaceutical and biopharmaceutical companies.
United States of America
DMAA
Develops, manufactures, and commercializes radiopharmaceuticals for diagnosis and treatment.
South Korea
176750
Dx & Vx Co., Ltd. Logo
A bio-healthcare company specializing in diagnostics and mRNA vaccine development.
South Korea
180400
DYNAVAX TECHNOLOGIES CORP Logo
Biopharmaceutical company developing and commercializing vaccines and adjuvant technology.
United States of America
DVAX
Dyne Therapeutics, Inc. Logo
Develops targeted therapies for genetically driven neuromuscular diseases.
United States of America
DYN
Manufactures veterinary pharmaceuticals and develops premium pet food.
South Korea
044960
Eckert & Ziegler Strahlen- und Medizintechnik AG Logo
A global provider of isotope technology for medical, scientific, and industrial use.
Germany
EUZ

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.